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Background: The StarClose® Vascular Closure System (Abbott Vascular Devices, Redwood City, CA) is a clip-based device that provides 
extravascular closure of the femoral arteriotomy site. The favorable safety and efficacy profile of the StarClose has been well described in patients 
with no documented peripheral arterial disease (PAD). The CLIPIT trial was the first randomized, controlled trial to evaluate the safety and efficacy of 
the StarClose device in patients with PAD undergoing percutaneous endovascular and coronary procedures.
Methods: This was a single center, prospective, randomized trial evaluating the StarClose device versus standard manual compression in patients 
with confirmed PAD undergoing percutaneous endovascular and coronary procedures. Patients were randomized in a 1:1 fashion to StarClose or 
manual compression at the conclusion of the index procedure. All patients received Duplex ultrasounds of the closure site within 7 days of the 
procedure to evaluate for vascular complications.
Results: 81 total patients were randomized to receive StarClose (n=39) or standard manual compression (n=42). Time to hemostasis was 
significantly lower in the StarClose group when compared to manual compression (2.98 ± 5.77 minutes versus 19.53 ± 8.74 minutes, p<0.0001). 
Procedural success was 92.3% (36/39) and device success was 87% (34/39). The rate of major complications in the StarClose group was 7.7% 
(3/39) versus 7.1% (3/42) in the manual compression group. Pseudoaneurysm or AV fistula was not seen with the StarClose. There were no deaths 
in either group.
Conclusions: The StarClose Vascular Closure System is safe and effective for closure of femoral arteriotomies in patients with peripheral arterial 
disease undergoing percutaneous endovascular and coronary procedures. The StarClose device significantly reduced the time to hemostasis when 
compared to standard manual compression. A large, muticenter, randomized trial is needed to definitively evaluate this extravascular closure system 
in patients with significant peripheral arterial disease.
